Evaluation of experimental greens-type hybrid bermudagrass selections by genetic profiling, morphological measurements, and field testing von Earp, Ryan

Volltext bestellen

Characterization of genetic diversity of greens‐type hybrid bermudagrass selections through SSR markers and morphological analysis von Earp, Ryan, Moss, Justin Quetone, Fang, Tilin, Anderson, Michael, Wu, Yanqi

Volltext

MerTK as a therapeutic target in glioblastoma von Wu, Jing, Frady, Lauren N, Bash, Ryan E, Cohen, Stephanie M, Schorzman, Allison N, Su, Yu-Ting, Irvin, David M, Zamboni, William C, Wang, Xiaodong, Frye, Stephen V, Ewend, Matthew G, Sulman, Erik P, Gilbert, Mark R, Earp, H Shelton, Miller, C Ryan

Volltext

Therapeutic Targeting of MERTK and BCL-2 in T-Cell and Early T-Precursor Acute Lymphoblastic Leukemia von Summers, Ryan J, Jain, Juhi, Vasileiadi, Eleana, Smith, Brittany, Chimenti, Madison L, Yeung, Tsz Y, Kelvin, James, Wang, Xiaodong, Frye, Stephen V, Earp, H Shelton, Tyner, Jeffrey W, Dreaden, Erik C, DeRyckere, Deborah, Graham, Douglas K

Volltext

MERTK receptor tyrosine kinase is a therapeutic target in melanoma von Schlegel, Jennifer, Sambade, Maria J, Sather, Susan, Moschos, Stergios J, Tan, Aik-Choon, Winges, Amanda, DeRyckere, Deborah, Carson, Craig C, Trembath, Dimitri G, Tentler, John J, Eckhardt, S Gail, Kuan, Pei-Fen, Hamilton, Ronald L, Duncan, Lyn M, Miller, C Ryan, Nikolaishvili-Feinberg, Nana, Midkiff, Bentley R, Liu, Jing, Zhang, Weihe, Yang, Chao, Wang, Xiaodong, Frye, Stephen V, Earp, H Shelton, Shields, Janiel M, Graham, Douglas K

Volltext

Trial of Solanezumab in Preclinical Alzheimer’s Disease von Sperling, Reisa A., Donohue, Michael C., Raman, Rema, Rafii, Michael S., Johnson, Keith, Masters, Colin L., van Dyck, Christopher H., Iwatsubo, Takeshi, Marshall, Gad A., Yaari, Roy, Mancini, Michele, Holdridge, Karen C., Case, Michael, Sims, John R., Aisen, Paul S.

Volltext

Contrast With Compression Therapy Enhances Muscle Function Recovery and Attenuates Glycogen Disruption After Exercise von Colantuono, Vincent M., Oakley, Ryan, Hatfield, Disa L., Penailillo, Luis, Lateef, Shabnam, Earp, Jacob E.

Volltext

The Effects Of Contrast With Compression Therapy On Muscle Recovery Post Exercise: 186 Board #2 May 27 9:30 AM - 11:00 AM von Lateef, Shabnam, Oakley, Ryan, Colantuno, Vinny, Lavellee, Robert, LaFortune, Anders, Hatfield, Disa L., McLinden, Jonathan, Earp, Jacob E.

Volltext

Therapeutic Targeting of Mertk and BCL-2 in T-Cell and Early T-Precursor Acute Lymphoblastic Leukemia von Summers, Ryan J, Jain, Juhi, Vasileiadi, Eleana, Smith, Brittany, Stout, Madison, Kelvin, James, Wang, Xiaodong, Frye, Stephen V, Earp, H. Shelton, Tyner, Jeffrey W., Dreaden, Erik, DeRyckere, Deborah, Graham, Douglas K

Volltext

MerTK inhibition decreases immune suppressive glioblastoma-associated macrophages and neoangiogenesis in glioblastoma microenvironment von Su, Yu-Ting, Butler, Madison, Zhang, Meili, Zhang, Wei, Song, Hua, Hwang, Lee, Tran, Andy D, Bash, Ryan E, Schorzman, Allison N, Pang, Ying, Yu, Guangyang, Zamboni, William C, Wang, Xiaodong, Frye, Stephen V, Miller, Christopher Ryan, Maric, Dragan, Terabe, Masaki, Gilbert, Mark R, Earp III, Henry Shelton, Wu, Jing

Volltext

Abstract A35: MERTK and BCL-2 as potential therapeutic targets in early T-precursor acute lymphoblastic leukemia von Summers, Ryan J., Minson, Katherine A., Wang, Xiaodong, Frye, Stephen V., Earp, H. Shelton, DeRyckere, Deborah, Graham, Douglas K.

Volltext

Abstract 1314: MERTK and BCL-2 as potential therapeutic targets in early T-precursor acute lymphoblastic leukemia von Summers, Ryan J., Minson, Katherine A., Vasileiadi, Eleana, Wang, Xiaodong, Frye, Steven V., Earp, H. Shelton, DeRyckere, Deborah, Graham, Douglas K.

Volltext

Mertk Is a Therapeutic Target in Early T-Precursor Acute Lymphoblastic Leukemia von Summers, Ryan J, Minson, Katherine A, Frye, Stephen V, Wang, Xiaodong, Earp, H. Shelton, DeRyckere, Deborah, Graham, Douglas K.

Volltext

Abstract 3339: MRX-2843, a dual MERTK and FLT3 inhibitor, mediates synergistic anti-leukemia activity in combination with BCL-2 inhibitors in acute myeloid leukemia and early T-cel... von Thapa, Aashis, Jain, Juhi, Summers, Ryan J., Kelvin, James M., Wang, Xiaodong, Frye, Stephen V., Earp, H. Shelton, Dreaden, Erik C., DeRyckere, Deborah, Graham, Douglas K.

Volltext

NT-38 MerTK AS A TARGET IN GLIOBLASTOMA von Wu, J., Huey, L., Bash, R. E., Cohen, S. M., Ewend, M. G., Wang, X., Graham, D. K., Frye, S. V., Earp, H. S., Miller, C. R.

Volltext

NT-38MerTK AS A TARGET IN GLIOBLASTOMA von Wu, Jing, Huey, Lauren, Bash, Ryan E., Cohen, Stephanie M., Ewend, Matthew G., Wang, Xiaodong, Graham, Douglas K., Frye, Stephen V., Earp, H. Shelton, Miller, C. Ryan

Volltext

Precluding incongruous behavior by aligning software requirements with security and privacy policies von Antón, Annie I, Earp, Julia B, Carter, Ryan A

Volltext

Abstract 3037: Mer receptor tyrosine kinase is a novel therapeutic target in melanoma von Schlegel, Jennifer, Sambade, Maria, Sather, Susan, Moschos, Stergios, Tan, Aik-Choon, Winges, Amanda, DeRyckere, Deborah, Carson, Craig C., Trembath, Dimitri G., Tentler, John J., Eckhardt, Gail, Kuan, Pei-Fen, Hamilton, Ronald L., Duncan, Lyn M., Miller, C. Ryan, Nikolaishvili-Feinberg, Nana, Midkiff, Bentley R., Wang, Xiaodong, Liu, Jing, Zhang, Weihe, Yang, Chao, Frye, Stephen V., Earp, H. Shelton, Shields, Janiel, Graham, Douglas K.

Volltext

The Routledge Handbook of Neuroethics von Johnson, L. Syd M, Rommelfanger, Karen S

Volltext